FDA sets up council for post-market review of vaccines, gene therapies
The FDA said the council is intended to improve accountability and transparency as biologic products grow increasingly complex, particularly in cell and gene therapy, a sector that has seen rapid regulatory expansion in recent years
360ยฐ PERSPECTIVE
Verified viewpoints, counter-arguments & evidence
"Proponents and sector analysts emphasize that this development strengthens institutional transparency, addresses long-standing public priorities, and establishes a foundation for durable systemic progress."
Related Stories
Winter heart health: Cardiologist explains why cold mornings increase heart attack risk and what precautions you should take
1 hour ago
Stomach cancer warning signs: Oncologist explains why you shouldn't ignore persistent acidity and indigestion
1 hour ago
From sleep patterns to physical activity: 5 daily habits that can make a difference to your bowel health
3 hours ago
Endocrinologist explains the effect of skipping breakfast on blood sugar levels, shares what healthy breakfast should look like
3 hours ago
Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].


Comment
0Upholding journalistic discourse. No registration required.
No comments yet. Share your perspective!